Jae Il Shin

Active 1983–2026

Also published as
Jae il Shin
306
Papers
26,601
Citations
74
h-index
283
i10-index

Citations

Citations per year for Jae Il Shin1983: 2 citations1984: 1 citations1985: 3 citations1986: 3 citations1987: 7 citations1988: 3 citations1989: 6 citations1990: 4 citations1991: 1 citations1992: 2 citations1994: 2 citations1995: 2 citations1997: 1 citations2003: 2 citations2005: 2 citations2006: 3 citations2007: 2 citations2008: 2 citations2009: 7 citations2010: 7 citations2011: 3 citations2012: 5 citations2013: 5 citations2014: 3 citations2015: 7 citations2016: 4 citations2017: 7 citations2018: 19 citations2019: 143 citations2020: 360 citations2021: 1,019 citations2022: 1,173 citations2023: 1,120 citations2024: 2,297 citations2025: 1,041 citations2026: 41 citations1993: no citations, so this year is not shown1996: no citations, so this year is not shown1998–2002: no citations, so these years are not shown2004: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,968 citing papers, 14.4% of this breakdownChina: 1,424 citing papers, 10.4% of this breakdownUnited Kingdom: 1,140 citing papers, 8.4% of this breakdownItaly: 842 citing papers, 6.2% of this breakdownGermany: 582 citing papers, 4.3% of this breakdownSpain: 557 citing papers, 4.1% of this breakdownCanada: 522 citing papers, 3.8% of this breakdownAustralia: 521 citing papers, 3.8% of this breakdownSouth Korea: 402 citing papers, 3% of this breakdownFrance: 401 citing papers, 2.9% of this breakdownNetherlands: 328 citing papers, 2.4% of this breakdownSweden: 300 citing papers, 2.2% of this breakdown
0%14.4%Other 34.1%

Fields

  • Medicine54.3%
  • Psychology11.1%
  • Biochemistry, Genetics and Molecular Biology10.1%
  • Immunology and Microbiology6.4%
  • Neuroscience6.1%
  • Health Professions3.6%
  • Other8.4%

Topics

  • COVID-19 and Mental Health2.6%
  • COVID-19 Clinical Research Studies2%
  • Long-Term Effects of COVID-191.8%
  • Schizophrenia research and treatment1.8%
  • SARS-CoV-2 and COVID-19 Research1.4%
  • Tryptophan and brain disorders1.1%
  • Other89.3%

Coauthors

All papers

Open in search
  1. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies

    Authors: , , , , , , , , , , , , , , - Molecular Psychiatry 2021 cited by 3,599

  2. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019

    Authors: , , , , , , , - Allergy 2023 cited by 391

  3. Burden of Neurological Disorders Across the US From 1990-2017

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Warren Lo, Giancarlo Logroscino, George A. Mensah, Ted R. Miller, Salahuddin Mohammed, Ali H. Mokdad, Maziar Moradi‐Lakeh, Shane D. Morrison, Veeresh Kumar N. Shivamurthy, Mohsen Naghavi, Emma Nichols, Bo Norrving, Christopher M Odell, Elisabetta Pupillo, Amir Radfar, Gregory A. Roth, Azadeh Shafieesabet, Aziz Sheikh, Sara Sheikhbahaei, Jae Il Shin, Jasvinder A. Singh, Timothy J. Steiner, Lars Jacob Stovner, Mitchell T. Wallin, Jordan Weiss, Chenkai Wu, Joseph R. Zunt, Jaimie D. Adelson, Christopher J L Murray - JAMA Neurology 2020 cited by 629

  4. Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Autoimmunity Reviews 2017 cited by 630

  5. Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019

    Authors: , , , , , , , , , , , , , , - Molecular Psychiatry 2023 cited by 510

  6. Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies

    Authors: , , , , , , , - European Heart Journal 2021 cited by 369

  7. Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jae Il Shin, Elena Dragioti - BMJ 2023 cited by 245

  8. Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lockdown: a systematic review

    Authors: , , , , , , , , - BMJ Open Sport & Exercise Medicine 2021 cited by 1,464

  9. Probability of Transition to Psychosis in Individuals at Clinical High Risk

    Authors: , , , , , , , , , , , , , , , , , , , - JAMA Psychiatry 2021 cited by 349

  10. Mortality rates in Alzheimer's disease and non-Alzheimer's dementias: a systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Healthy Longevity 2021 cited by 207

  11. Incidence, prevalence, and global burden of autism spectrum disorder from 1990 to 2019 across 204 countries

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Molecular Psychiatry 2022 cited by 211

  12. Risk and protective factors for mental disorders beyond genetics: an evidence‐based atlas

    Authors: , , , , , , , , , , , , , - World Psychiatry 2021 cited by 311

  13. Environmental risk factors, protective factors, and peripheral biomarkers for ADHD: an umbrella review

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Psychiatry 2020 cited by 263

  14. Incidence, prevalence, and global burden of ADHD from 1990 to 2019 across 204 countries: data, with critical re-analysis, from the Global Burden of Disease study

    Authors: , , , , , , , , , , , , , , , , , , , , , - Molecular Psychiatry 2023 cited by 180

  15. Global Incidence and Prevalence of Eosinophilic Esophagitis, 1976–2022: A Systematic Review and Meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2023 cited by 173

  16. Induction and maintenance treatment of inflammatory bowel disease: A comprehensive review

    Authors: , , , , , , , - Autoimmunity Reviews 2019 cited by 214

  17. Assessing the quality of studies in meta‐research: Review/guidelines on the most important quality assessment tools

    Authors: , , , , , , , , , - Pharmaceutical Statistics 2020 cited by 225

  18. Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fraction

    Authors: , , , , , , , , , , , , , , , , , , , , - World Psychiatry 2023 cited by 117

  19. Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , - Annals of Internal Medicine 2024 cited by 67

  20. Treatment of eating disorders: A systematic meta-review of meta-analyses and network meta-analyses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Neuroscience & Biobehavioral Reviews 2022 cited by 279

  21. Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability

    Authors: , , , , , , , , , , , , , - Brain Behavior and Immunity 2021 cited by 185

  22. Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4 717 839 people

    Authors: , , , , , , , , , , , , - The Lancet Psychiatry 2019 cited by 238

  23. A systematic review and meta‐analysis of long‐term sequelae of COVID‐19 2‐year after SARS‐CoV‐2 infection: A call to action for neurological, physical, and psychological sciences

    Authors: , , , , , , , , , , , - Journal of Medical Virology 2023 cited by 131

  24. Immunopathogenesis and treatment of cytokine storm in COVID-19

    Authors: , , , , , , , - Theranostics 2020 cited by 470